BWAY
Price
$11.42
Change
-$0.31 (-2.64%)
Updated
Jun 12 closing price
Capitalization
86.77M
54 days until earnings call
PLSE
Price
$16.18
Change
-$0.55 (-3.29%)
Updated
Jun 12 closing price
Capitalization
481.01M
54 days until earnings call
Interact to see
Advertisement

BWAY vs PLSE

Header iconBWAY vs PLSE Comparison
Open Charts BWAY vs PLSEBanner chart's image
BrainsWay
Price$11.42
Change-$0.31 (-2.64%)
Volume$27.22K
Capitalization86.77M
Pulse Biosciences
Price$16.18
Change-$0.55 (-3.29%)
Volume$299.19K
Capitalization481.01M
BWAY vs PLSE Comparison Chart
Loading...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BWAY vs. PLSE commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a StrongBuy and PLSE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (BWAY: $11.73 vs. PLSE: $16.73)
Brand notoriety: BWAY and PLSE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BWAY: 332% vs. PLSE: 108%
Market capitalization -- BWAY: $86.77M vs. PLSE: $481.01M
BWAY [@Medical Specialties] is valued at $86.77M. PLSE’s [@Medical Specialties] market capitalization is $481.01M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 0 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • BWAY’s FA Score: 0 green, 5 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, PLSE is a better buy in the long-term than BWAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 6 TA indicator(s) are bullish while PLSE’s TA Score has 2 bullish TA indicator(s).

  • BWAY’s TA Score: 6 bullish, 4 bearish.
  • PLSE’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BWAY is a better buy in the short-term than PLSE.

Price Growth

BWAY (@Medical Specialties) experienced а +12.14% price change this week, while PLSE (@Medical Specialties) price change was -4.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.00%. For the same industry, the average monthly price growth was +1.65%, and the average quarterly price growth was +1.66%.

Reported Earning Dates

BWAY is expected to report earnings on Aug 06, 2025.

PLSE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($481M) has a higher market cap than BWAY($86.8M). BWAY YTD gains are higher at: 24.390 vs. PLSE (-7.065). BWAY has higher annual earnings (EBITDA): -8.43M vs. PLSE (-42.37M). PLSE (44.4M) and BWAY (44.2M) have equal amount of cash in the bank . BWAY has less debt than PLSE: BWAY (754K) vs PLSE (9.14M). BWAY has higher revenues than PLSE: BWAY (28.8M) vs PLSE (0).
BWAYPLSEBWAY / PLSE
Capitalization86.8M481M18%
EBITDA-8.43M-42.37M20%
Gain YTD24.390-7.065-345%
P/E RatioN/AN/A-
Revenue28.8M0-
Total Cash44.2M44.4M100%
Total Debt754K9.14M8%
FUNDAMENTALS RATINGS
BWAY vs PLSE: Fundamental Ratings
BWAY
PLSE
OUTLOOK RATING
1..100
2711
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
6986
SMR RATING
1..100
8598
PRICE GROWTH RATING
1..100
3849
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLSE's Valuation (58) in the Medical Specialties industry is in the same range as BWAY (74). This means that PLSE’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as PLSE (86). This means that BWAY’s stock grew similarly to PLSE’s over the last 12 months.

BWAY's SMR Rating (85) in the Medical Specialties industry is in the same range as PLSE (98). This means that BWAY’s stock grew similarly to PLSE’s over the last 12 months.

BWAY's Price Growth Rating (38) in the Medical Specialties industry is in the same range as PLSE (49). This means that BWAY’s stock grew similarly to PLSE’s over the last 12 months.

BWAY's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as PLSE (100). This means that BWAY’s stock grew similarly to PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYPLSE
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 28 days ago
80%
Bearish Trend 24 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFGRX51.720.23
+0.45%
Commerce Growth
CGRYX33.920.11
+0.33%
Invesco Comstock Select Y
CDOZX39.270.09
+0.23%
Columbia Dividend Opportunity Inst
FIADX55.64N/A
N/A
Fidelity Advisor International Discv I
LEVOX11.50N/A
N/A
Lazard US Equity Concentrated Open

BWAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with OFIX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
+2.36%
OFIX - BWAY
35%
Loosely correlated
-1.64%
BFLY - BWAY
30%
Poorly correlated
-3.45%
IRMD - BWAY
29%
Poorly correlated
+0.11%
CLPT - BWAY
29%
Poorly correlated
-3.31%
BLFS - BWAY
28%
Poorly correlated
-0.71%
More

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-3.29%
CERS - PLSE
40%
Loosely correlated
-3.52%
SRTS - PLSE
35%
Loosely correlated
-2.55%
STXS - PLSE
32%
Poorly correlated
-2.25%
ARAY - PLSE
30%
Poorly correlated
N/A
SIBN - PLSE
29%
Poorly correlated
-2.92%
More